期刊文献+
共找到70篇文章
< 1 2 4 >
每页显示 20 50 100
P2RX1 Influences the Prognosis of Ph+/Ph-Like ALL through Energy and Calcium Metabolism
1
作者 Xiangmei Ye Baoyi Yang +12 位作者 Xin Zhang Luyuan Yang Likun Zhang Qin Ren Xiaobing Li Leiguang Feng Lanlan Wei Peng Song Yuqing Ye Xin Lian Yujuan Gao Haidi Tang Zhiyu Liu 《Oncology Research》 2026年第1期279-296,共18页
Objectives:Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia and Philadelphia-like B-cell acute lymphoblastic leukemia(Ph+/Ph-like ALL)constitute the majority of relapsed/refractory B-ALL(R/R B-ALL)... Objectives:Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia and Philadelphia-like B-cell acute lymphoblastic leukemia(Ph+/Ph-like ALL)constitute the majority of relapsed/refractory B-ALL(R/R B-ALL)cases,highlighting an urgent need to discover new therapeutic targets.This study aims to elucidate the mechanisms underlying poor prognosis in Ph+/Ph-like ALL through transcriptome sequencing and functional cytological assays,with the goal of informing new clinical treatment strategies.Results:Transcriptomic analysis of Ph+/Ph-like ALL patients revealed that low expression of P2X Purinoceptor 1(P2RX1)was associated with unfavorable outcomes.Specifically,patients with poor prognosis and low P2RX1 expression exhibited downregulation of genes involved in energy and calcium metabolism pathways,along with upregulation of genes governing key cellular processes such as cell proliferation(e.g.,MYC),cell cycle progression(e.g.,CCND2),and apoptosis inhibition(e.g.,DASP6).Cellular experiments demonstrated that SUP-B15 cells overexpressing P2RX1 displayed elevated intracellular levels of ATP,calcium,and glucose,together with enhanced glycolytic capacity,compared to empty vector controls.Treatment of SUP-B15 cells with dexamethasone(Dex),Imatinib,or their combination significantly suppressed proliferation and promoted apoptosis,which was accompanied by increases in intracellular ATP,calcium,and glucose.Moreover,exogenous ATP administration(a P2RX1 agonist)enhanced apoptosis and inhibited proliferation in control cells.Conversely,treatment with NF449(a P2RX1 inhibitor)increased proliferation in both P2RX1-overexpressing and control SUP-B15 cells.Conclusion:Our findings indicate that P2RX1 may exert this function through modulating energy metabolism and calcium homeostasis,resulting in elevated intracellular calcium levels.Sustained elevation of calcium promotes apoptosis,whereas exogenous ATP activates P2RX1,enhances calcium influx,and attenuates the suppression of apoptosis associated with P2RX1 underexpression,ultimately correlating with improved treatment response. 展开更多
关键词 philadelphia chromosome-positive acute lymphoblastic leukemia(Ph+ALL) philadelphia chromosome-like B-cell acute lymphoblastic leukemia(Ph-like ALL) transcriptome sequencing P2X purinoceptor 1
暂未订购
The Philadelphia chromosome in leukemogenesis 被引量:7
2
作者 Zhi-Jie Kang Yu-Fei Liu +8 位作者 Ling-Zhi Xu Zi-Jie Long Dan Huang Ya Yang Bing Liu Jiu-Xing Feng Yu-Jia Pan Jin-Song Yan Quentin Liu 《Chinese Journal of Cancer》 SCIE CAS CSCD 2016年第6期5-19,共15页
The truncated chromosome 22 that results from the reciprocal translocation t(9;22)(q34;q11) is known as the Phila?delphia chromosome(Ph) and is a hallmark of chronic myeloid leukemia(CML).In leukemia cells,Ph not only... The truncated chromosome 22 that results from the reciprocal translocation t(9;22)(q34;q11) is known as the Phila?delphia chromosome(Ph) and is a hallmark of chronic myeloid leukemia(CML).In leukemia cells,Ph not only impairs the physiological signaling pathways but also disrupts genomic stability.This aberrant fusion gene encodes the breakpoint cluster region?proto?oncogene tyrosine?protein kinase(BCR?ABL1) oncogenic protein with persistently enhanced tyrosine kinase activity.The kinase activity is responsible for maintaining proliferation,inhibiting differentia?tion,and conferring resistance to cell death.During the progression of CML from the chronic phase to the accelerated phase and then to the blast phase,the expression patterns of different BCR?ABL1 transcripts vary.Each BCR?ABL1 transcript is present in a distinct leukemia phenotype,which predicts both response to therapy and clinical outcome.Besides CML,the Ph is found in acute lymphoblastic leukemia,acute myeloid leukemia,and mixed?phenotype acute leukemia.Here,we provide an overview of the clinical presentation and cellular biology of different phenotypes of Ph?positive leukemia and highlight key findings regarding leukemogenesis. 展开更多
关键词 Chronic myeloid leukemia BCR-ABL1 philadelphia chromosome TRANSLOCATIONS Signaling pathway
暂未订购
Philadelphia chromosome-positive leukemia stem cells in acute lymphoblastic leukemia and tyrosine kinase inhibitor therapy 被引量:4
3
作者 Xavier Thomas 《World Journal of Stem Cells》 SCIE CAS 2012年第6期44-52,共9页
Leukemia stem cells(LSCs),which constitute a minority of the tumor bulk,are functionally defined on the basis of their ability to transfer leukemia into an immunodeficient recipient animal.The presence of LSCs has bee... Leukemia stem cells(LSCs),which constitute a minority of the tumor bulk,are functionally defined on the basis of their ability to transfer leukemia into an immunodeficient recipient animal.The presence of LSCs has been demonstrated in acute lymphoblastic leukemia(ALL),of which ALL with Philadelphia chromosome-positive(Ph+).The use of imatinib,a tyrosine kinase inhibitor(TKI),as part of front-line treatment and in combination with cytotoxic agents,has greatly improved the proportions of complete response and molecular remission and the overall outcome in adults with newly diagnosed Ph+ ALL.New challenges have emerged with respect to induction of resistance to imatinib via Abelson tyrosine kinase mutations.An important recent addition to the arsenal against Ph+ leukemias in general was the development of novel TKIs,such as nilotinib and dasatinib.However,in vitro experiments have suggested that TKIs have an antiproliferative but not an antiapoptotic or cytotoxic effect on the most primitive ALL stem cells.None of the TKIs in clinical use target the LSC.Second generation TKI dasatinib has been shown to have a more profound effect on the stem cell compartment but the drug was still unable to kill the most primitive LSCs.Allogeneic stem cell transplantation(SCT) remains the only curative treatment available for these patients.Several mechanisms were proposed to explain the resistance of LSCs to TKIs in addition to mutations.Hence,TKIs may be used as a bridge to SCT rather than monotherapy or combination with standard chemotherapy.Better understanding the biology of Ph+ ALL will open new avenues for effective management.In this review,we highlight recent findings relating to the question of LSCs in Ph+ ALL. 展开更多
关键词 Acute LYMPHOBLASTIC LEUKEMIA philadelphia CHROMOSOME TYROSINE KINASE inhibitors LEUKEMIA stem cells Prognosis
暂未订购
Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs:A literature review 被引量:3
4
作者 Mariana Miranda Sampaio Maria Luísa Cordeiro Santos +14 位作者 Hanna Santos Marques Vinícius Lima de Souza Gonçalves Glauber Rocha Lima Araújo Luana Weber Lopes Jonathan Santos Apolonio Camilo Santana Silva Luana Kauany de SáSantos Beatriz Rocha Cuzzuol Quézia Estéfani Silva Guimarães Mariana Novaes Santos Breno Bittencourt de Brito Filipe Antônio França da Silva Márcio Vasconcelos Oliveira Cláudio Lima Souza Fabrício Freire de Melo 《World Journal of Clinical Oncology》 CAS 2021年第2期69-94,共26页
Chronic myeloid leukemia(CML)is a myeloproliferative neoplasm and was the first neoplastic disease associated with a well-defined genotypic anomaly―the presence of the Philadelphia chromosome.The advances in cytogene... Chronic myeloid leukemia(CML)is a myeloproliferative neoplasm and was the first neoplastic disease associated with a well-defined genotypic anomaly―the presence of the Philadelphia chromosome.The advances in cytogenetic and molecular assays are of great importance to the diagnosis,prognosis,treatment,and monitoring of CML.The discovery of the breakpoint cluster region(BCR)-Abelson murine leukemia(ABL)1 fusion oncogene has revolutionized the treatment of CML patients by allowing the development of targeted drugs that inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein.Tyrosine kinase inhibitors(known as TKIs)are the standard therapy for CML and greatly increase the survival rates,despite adverse effects and the odds of residual disease after discontinuation of treatment.As therapeutic alternatives,the subsequent TKIs lead to faster and deeper molecular remissions;however,with the emergence of resistance to these drugs,immunotherapy appears as an alternative,which may have a cure potential in these patients.Against this background,this article aims at providing an overview on CML clinical management and a summary on the main targeted drugs available in that context. 展开更多
关键词 Chronic myeloid leukemia Breakpoint cluster region-Abelson murine leukemia IMMUNOTHERAPY Tyrosine kinase inhibitors philadelphia chromosome Diagnosis
暂未订购
Efficacy of Nilotinib versus Imatinib in Philadelphia Positive Patients with Chronic Myeloid Leukemia in Early Chronic Phase Who Have a Warning Molecular Response to Imatinib
5
作者 Amen Hamdy Zaky Aly Ahmed EL Sayed Mohammed Khalifa Esraa Abdallah Abdelkariem Gadallah 《Journal of Cancer Therapy》 2018年第11期883-897,共15页
Background and Objectives: Chronic myeloid leukemia (CML) accounts for approximately 15% of newly diagnosed cases of leukemia in adults. In this study, the efficacy of nilotinib at 400 mg BID is compared with imatinib... Background and Objectives: Chronic myeloid leukemia (CML) accounts for approximately 15% of newly diagnosed cases of leukemia in adults. In this study, the efficacy of nilotinib at 400 mg BID is compared with imatinib at 400 mg BID in CML patients with suboptimal molecular response after at least 12 months of daily dose 400 mg of imatinib therapy. Patients and Methods: This study included a total number of 50 patients, divided into two groups (25 patients each). The first group (Group I): Patients received imatinib at 400 mg BID, second group (Group II): Patients had a suboptimal molecular response to imatinib and received nilotinib at 400 mg BID in early chronic phase. During the two years period of data collection, the primary end included median survival. The secondary end included response rate, type of response, duration of response and progression free survival. Also side effects were recorded. Patients were followed up every month by complete and differential blood counts, liver function test, renal function test and (PCR) every three months for two year. Results: Nilotinib group had significantly higher frequency of major molecular response (MMR) where 23 (92%) patients achieved it while only 16 (64%) patients in Imatinib group achieved MMR (P = 0.01). Nilotinib had better toxicities profile than Imatinib. Conclusion: Both Nilotinib and high dose Imatinib achieved response in CML patients with suboptimal response with rapid and deeper molecular response, better survival outcomes and less side effects in nilotinib. 展开更多
关键词 NILOTINIB IMATINIB philadelphia POSITIVE Chronic Myeloid Leukemia PATIENTS WARNING Molecular Response
暂未订购
China Tourism Goes to Philadelphia Travel & Adventure Show
6
《China & The World Cultural Exchange》 2019年第3期7-7,共1页
The Sixth Philadelphia Travel & Adventure Show took place at Pennsylvania Convention Center in Philadelphia, the USA, from March 9 to 1 0. China National Tourist Office, New York, used pandas and Peking Opera symb... The Sixth Philadelphia Travel & Adventure Show took place at Pennsylvania Convention Center in Philadelphia, the USA, from March 9 to 1 0. China National Tourist Office, New York, used pandas and Peking Opera symbolic meaning as the key visual style,"Beautiful China" national tourism brand as the theme to present "China Beyond Imaginations , in Philadelphia, delivered news about tourism in China and caught attention of lots of participants. 展开更多
关键词 TOURISM philadelphia TRAVEL PARTICIPANTS
在线阅读 下载PDF
NCPA May Festival 2019 Closing Concert: The Philadelphia Orchestra
7
《China Today》 2019年第5期9-9,共1页
Date: May 17-18, 2019 Venue: National Center for the Performing Arts Prices: RMB 280, 480, 600, 780, 900, 1080, 1280 The Philadelphia Orchestra is one of the preeminent orchestras in the world, renowned for its distin... Date: May 17-18, 2019 Venue: National Center for the Performing Arts Prices: RMB 280, 480, 600, 780, 900, 1080, 1280 The Philadelphia Orchestra is one of the preeminent orchestras in the world, renowned for its distinctive sound, desired for its keen ability to capture the hearts and imaginations of audiences, and admired for a legacy of imagination and innovation on and off the concert stage. 展开更多
关键词 NCPA philadelphia ORCHESTRA
暂未订购
The Philadelphia Orchestra’s Triumphal Return to China
8
《China & The World Cultural Exchange》 1993年第5期38-40,共3页
MUSIC is an internationalart,enabling people allover the world to com-municate with and understand eachother.The first cultural troupe sentby the American government to visitChina 20 years ago was the Philadel-phia Or... MUSIC is an internationalart,enabling people allover the world to com-municate with and understand eachother.The first cultural troupe sentby the American government to visitChina 20 years ago was the Philadel-phia Orchestra.Their perform-ances contributed greatly to Sino-American cultural exchange andpromoted friendship between theAmerican and Chinese people.InMay 1993 the Philadelphia Orches-tra came to China again as theAmerican people’s cultural 展开更多
关键词 philadelphia enabling AGAIN music SONATA scene PERFORMING honored MINOR quickly
在线阅读 下载PDF
Unusual cytogenetic abnormalities associated with Philadelphia chromosome
9
作者 Sanjeev Kumar Sharma Anil Handoo +1 位作者 Dharma Choudhary Nitin Gupta 《World Journal of Hematology》 2014年第3期115-117,共3页
Cytogenetic abnormalities are the hallmark of leukemias. We report here two cases of unusual cytogenetic abnormalities associated with Philadelphia chromosome, one with mixed phenotypic acute leukemia showing monosomy... Cytogenetic abnormalities are the hallmark of leukemias. We report here two cases of unusual cytogenetic abnormalities associated with Philadelphia chromosome, one with mixed phenotypic acute leukemia showing monosomy 7 and t(9;22)(q34;q11.2) and the other with chronic myeloid leukemia and additional translocation involving chromosomes 10 and 13. Both patients achieved complete remission following imatinib based treatment. 展开更多
关键词 philadelphia CHROMOSOME CYTOGENETIC ABNORMALITIES
暂未订购
Damage Mechanism of CK2 and IKAROS in Philadelphia Like Acute Lymphoblastic Leukemia
10
作者 Ignacio Vélez-Rodríguez Victoria Carranza-Aranda 《Journal of Biosciences and Medicines》 2024年第4期49-59,共11页
Acute lymphoblastic leukemia (ALL) is characterized by immature and poorly differentiated B lymphocytes in large numbers in the blood. B cells are distinct from the cell types involved in their development (common lym... Acute lymphoblastic leukemia (ALL) is characterized by immature and poorly differentiated B lymphocytes in large numbers in the blood. B cells are distinct from the cell types involved in their development (common lymphoid progenitor cells, pro-B cells, pre-B cells, and mature cells). The process of B cell maturation depends on precise communication within the cell: signals activate specific genes that are essential for proper development. Errors in this intricate signaling network can lead to issues with B cell function and contribute to disease. B-lineage acute lymphoid leukemias, malignancies of precursor-stage B lymphoid cells inhibit lymphoid differentiation, leading to abnormal cell proliferation and survival. The process of developing leukemia (leukemogenesis) can be triggered by an overproduction of both hematopoietic stem cells (the cells that form all blood cells) and the immature versions of white blood cells called lymphoblasts. Acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (ALL Ph) is classified as a high-risk manifestation of the disease, this chromosome is the product of the reciprocal translocation, whose product is a BCR-ABL fusion protein. It is a highly active tyrosine kinase that can transform hematopoietic cells into cytokine-independent. Hyperphosphorylation cascades inhibit the differentiating function of IKZF1 as a tumor suppressor gene which leads to an abnormal proliferation of B cells due to the presence of the Philadelphia chromosome;it inhibits the differentiating process, leukemogenesis involving immature B cells in the bloodstream can result from the uncontrolled growth and division of hematopoietic stem cells and immature lymphoblasts (the precursors to B cells). 展开更多
关键词 Acute Lymphoblastic Leukemia IKAROS DEPHOSPHORYLATION philadelphia Chromosome CK2
暂未订购
The Chargantaor Dinosaur in Philadelphia
11
《China & The World Cultural Exchange》 1998年第6期47-47,共1页
关键词 The Chargantaor Dinosaur in philadelphia
在线阅读 下载PDF
A heartwarming encounter at the airport
12
作者 孙朝岚 《疯狂英语(新读写)》 2025年第9期29-31,76,共4页
1 On May 19,2025,I had the pleasure of meeting two football players from North Carolina Central University in the Philadelphia airport as we were all headed back to Raleigh,NC.To protect their privacy,I will use only ... 1 On May 19,2025,I had the pleasure of meeting two football players from North Carolina Central University in the Philadelphia airport as we were all headed back to Raleigh,NC.To protect their privacy,I will use only the initials of their first names-L and N. 展开更多
关键词 AIRPORT North Carolina Central University philadelphia football players Raleigh PRIVACY heartwarming encounter
暂未订购
费城国家独立历史公园
13
作者 李常磊 于薇 《语言教育》 2001年第5期11-12,共2页
在独立战争和建国初期作为美国首都的费城(Philadelphia),在美国历史上占有十分重要的位置。它现在不仅是宾夕法尼亚州(the State of Pennsylvania)的最大城市,而且是仅次于纽约、芝加哥、洛杉矶的美国第4大城市。1948年美国国会通过法... 在独立战争和建国初期作为美国首都的费城(Philadelphia),在美国历史上占有十分重要的位置。它现在不仅是宾夕法尼亚州(the State of Pennsylvania)的最大城市,而且是仅次于纽约、芝加哥、洛杉矶的美国第4大城市。1948年美国国会通过法案,将费城中心独立厅周围所有历史性建筑加以保护,并为此成立历史公园——“ 展开更多
关键词 美国首都 美国国会 国家独立 philadelphia 大城市 PENNSYLVANIA 《独立宣言》 美国宪法 英语系 宾夕法尼亚州
在线阅读 下载PDF
A novel t(3;12)(q21;p13) translocation in a patient with accelerated chronic myeloid leukemia after imatinib and nilotinib therapy 被引量:1
14
作者 Ayda Bennour Ikram Tabka +4 位作者 Yosra Ben Youssef Zahra Kmeira Abderrahim Khelif Ali Saad Halima Sennana 《Cancer Biology & Medicine》 SCIE CAS CSCD 2013年第1期47-51,共5页
The acquisition of secondary chromosomal aberrations in chronic myeloid leukemia (CML) patients with Philadelphia chromosome-positive (Ph+) karyotype signifies clonal evolution associated with the progression of the d... The acquisition of secondary chromosomal aberrations in chronic myeloid leukemia (CML) patients with Philadelphia chromosome-positive (Ph+) karyotype signifies clonal evolution associated with the progression of the disease to its accelerated or blastic phase. Therefore, these aberrations have clinical and biological significance. T(3;12)(q26;p13), which is a recurrent chromosomal aberration observed in myeloid malignancies, is typically associated with dysplasia of megakaryocytes, multilineage involvement, short duration of any blastic phase, and extremely poor prognosis. We have identified a recurrent reciprocal translocation between chromosomes 3 and 12 with different breakpoint at bands 3q21 in the malignant cells from a 28-year-old man. The patient was initially diagnosed as having Ph+ CML in the chronic phase. The t(3;12)(q21;p13) translocation occurred 4 years after the patient was first diagnosed with CML while undergoing tyrosine kinase inhibitor therapy. We confirmed the t(3;12)(q21;p13) translocation via fluorescence in situ hybridization assay by using whole-chromosome paint probes for chromosomes 3 and 12. Our findings demonstrate that, similar to other recurrent translocations involving 3q26 such as t(3;3) and t(3;21), the t(3;12)(q21;p13) translocation is implicated not only in myelodysplastic syndrome and acute myeloid leukemia but also in the progression of CML. These findings extend the disease spectrum of this cytogenetic aberration. 展开更多
关键词 philadelphia chromosome t(3 12)(q21 p13) chronic myeloid leukemia accelerated phase fluorescence in situhybridization
暂未订购
LAF峰会召开,议题:风景园林与未来 被引量:1
15
作者 蒋鑫 《风景园林》 2016年第6期10-10,共1页
据asla.org讯6月10日到11日,由美国风景园林基金会(Landscape Architecture Foundation,简称LAF)组织的风景园林峰会在美国费城(Philadelphia)召开,会议邀请了对21世纪风景园林行业做出卓越贡献和产生巨大推动的全球顶尖风景园林师... 据asla.org讯6月10日到11日,由美国风景园林基金会(Landscape Architecture Foundation,简称LAF)组织的风景园林峰会在美国费城(Philadelphia)召开,会议邀请了对21世纪风景园林行业做出卓越贡献和产生巨大推动的全球顶尖风景园林师及从业者进行演讲和主题讨论。 展开更多
关键词 风景园林 LAF 主题讨论 设计学院 philadelphia 宾夕法尼亚大学 美国费城 园林界 景观设计 麦克哈格
在线阅读 下载PDF
Howarcl Koberts' Hypatta oJ Alexanclrta: A Form of Neoplatonic Beauty 被引量:1
16
作者 Liana De Girolami Cheney 《Journal of Literature and Art Studies》 2014年第12期1080-1092,共13页
This essay examines an American 19th-century sculpture, Howard Roberts' Hypatia, both historically and aesthetically (see Figures 1 and 2). Problems of interpretation are found at both levels because of limited doc... This essay examines an American 19th-century sculpture, Howard Roberts' Hypatia, both historically and aesthetically (see Figures 1 and 2). Problems of interpretation are found at both levels because of limited documentation. However, a speculative analysis adapting Plotinus' notions on the "delight of the intellect" and of "seeing" assist in considering beauty in the carved form, even if the subject is grave. What prompted this commission and who commissioned this work are questions to be considered. 展开更多
关键词 19th Century American Sculpture Howard Roberts Hypatia NEOPLATONISM philadelphia
在线阅读 下载PDF
Urban Journalism: Street by Street 被引量:1
17
作者 Christopher Harper 《Journal of Literature and Art Studies》 2012年第6期641-650,共10页
The website philadelphianeighborhoods.com provides news coverage about more than 30 underreported and underserved communities in Philadelphia. Affiliated with Temple University, the website and bimonthly printed editi... The website philadelphianeighborhoods.com provides news coverage about more than 30 underreported and underserved communities in Philadelphia. Affiliated with Temple University, the website and bimonthly printed editions focus on hyperlocal journalism, or journalism at the street-by-street level. The website has won numerous state, regional, and national awards for its coverage. The goals focus on many aspects of journalism, but this paper will address the successes and failures of this hyperlocal approach and the potential applicability for other organizations. 展开更多
关键词 multimedia journalism philadelphia philadelphianeighborhoods.com hyperlocal journalism
在线阅读 下载PDF
Chinese Journal of Chemical Engineering
18
《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2014年第10期1180-1180,共1页
This journal is selected for full coverage in Current Contents?/Engineering,Computing&Technology(CC?/EC&T),and appears in SciSearch? and Research Alert?,Institute for Scientific Information,Philadelphia,USA.It... This journal is selected for full coverage in Current Contents?/Engineering,Computing&Technology(CC?/EC&T),and appears in SciSearch? and Research Alert?,Institute for Scientific Information,Philadelphia,USA.It is abstracted and indexed in EI,Chemical Abstracts,Science Abstracts(Russia),Fluid Abstracts,and Cambridge Scientific Abstracts.Its electronic edition for full text 展开更多
关键词 ALERT RUSSIA philadelphia CAMBRIDGE edition COVERAGE http
在线阅读 下载PDF
About the Cover
19
《Chinese Journal of Cancer》 SCIE CAS CSCD 2016年第6期4-4,共1页
Chronic myeloid leukemia(CML)accounts for 15%-20%of all adult leukemias.The Philadelphia chromosome(Ph)is the truncated chromosome 22 generated by the reciprocal translocation t(9;22)(q34;q11)and was first identified ... Chronic myeloid leukemia(CML)accounts for 15%-20%of all adult leukemias.The Philadelphia chromosome(Ph)is the truncated chromosome 22 generated by the reciprocal translocation t(9;22)(q34;q11)and was first identified in 1960 in a patient with CML.Translocation of the proto-oncogene tyrosine-protein kinase(ABL1)gene located on chromosome 9 to the breakpoint cluster region(BCR)gene located on chromosome 22 results in a BCR-ABL1 fusion gene on the Ph. 展开更多
关键词 CHROMOSOME TRANSLOCATION ONCOGENE philadelphia proto MYELOID TRUNCATED reciprocal
暂未订购
干扰素治疗白血病 被引量:1
20
作者 增田道彦 胡宜 《日本医学介绍》 2003年第5期203-204,共2页
近年来 ,干扰素已广泛地应用于各种难治性疾病的治疗 ,而且疗效优异。在恶性肿瘤、难治性病毒性肝炎等的治疗上 ,尤其引人瞩目。为进一步开拓干扰素治疗的适应证、合理地发挥干扰素的治疗优势 ,日本医师会杂志 2 0 0 2年第 12 8卷 ,第 7... 近年来 ,干扰素已广泛地应用于各种难治性疾病的治疗 ,而且疗效优异。在恶性肿瘤、难治性病毒性肝炎等的治疗上 ,尤其引人瞩目。为进一步开拓干扰素治疗的适应证、合理地发挥干扰素的治疗优势 ,日本医师会杂志 2 0 0 2年第 12 8卷 ,第 7期 ,刊出特集———インタ フエ ロンの临床 ,全集总结、回顾了近 2 0年来 ,干扰素在多个领域、多种疾病中的治疗成果。 展开更多
关键词 慢性粒细胞白血病 干扰素 philadelphia染色体 细胞遗传学作用 用药剂量 不良反应 联合用药
暂未订购
上一页 1 2 4 下一页 到第
使用帮助 返回顶部